Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Health Care
  • News

Encompass Health Announces Plans To Build 50-Bed Inpatient Rehabilitation Hospital In Daytona Beach, Florida

By Michael Horton
November 21, 6:13 PM
Encompass Health Corp. (NYSE:EHC) today announced it plans to build a freestanding, 50-bed inpatient rehabilitation hospital in Daytona Beach, Florida. The hospital will be located at the southwest corner of

EHC

Read More
1 minute read
  • News
  • Offerings

BioSig Technologies Says On Nov. 18, 2022 Co. Entered Into Securities Purchase Agreement With Certain Accredited Investors To Which Co. Sold An Aggregate Of 3.5M Shares At $0.41/Share

By Michael Horton
November 21, 6:13 PM
-SEC Filing

BSGM

Read More
2 minute read
  • Legal
  • News

Sterigenics Issues Statement On Favorable Verdict In Fornek Trial

By Michael Horton
November 21, 6:08 PM
In response to numerous inquiries, Sterigenics®, a business of Sotera Health (NASDAQ:SHC), and a global leader in comprehensive sterilization services, today issued the following statement regarding the verdict in

SHC

Read More
2 minute read
  • News

HumanCo Acquisition Announces Liquidation, Co. Will Redeem All Outstanding Shares At ~$10.08/Share

By Michael Horton
November 21, 6:06 PM
HumanCo Acquisition Corp. (NASDAQ:HMCO, HMCOU and HMCOW)))), announced today that, due to its anticipated inability to consummate an initial business combination within the time period required by its Amended and

HMCO

Read More
2 minute read
  • M&A
  • News

Norfolk Southern To Purchase Assets Of Cincinnati Southern Railway For $1.62B

By Michael Horton
November 21, 6:04 PM
Norfolk Southern Corporation (NYSE:NSC) announced today the execution of a purchase agreement under which the company's operating subsidiary, Norfolk Southern Railway Company, will acquire substantially all of the

NSC

Read More
1 minute read
  • Earnings
  • News

ZTO Express (Cayman) Q3 EPS $0.33 Beats $0.18 Estimate, Sales $1.26B Beat $1.09B Estimate

By Michael Horton
November 21, 6:03 PM
ZTO Express (Cayman) (NYSE:ZTO) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.18 by 83.33 percent. This is a 50 percent increase over earnings of $0.22 per share from the

ZTO

Read More
1 minute read
  • News

Mesa Laboratories Says Has No Other Material Revenues For Expanded Carrier Screening With Other Customers

By Michael Horton
November 21, 6:02 PM
-Reuters

MLAB

Read More
1 minute read
  • News

Mesa Laboratories Says Received Notice That Sema4 Is Exiting Reproductive Health Screening Business

By Michael Horton
November 21, 6:00 PM
-Reuters

MLAB

Read More
1 minute read
  • Guidance
  • News

Dell Technologies CFO Says Back Half Of Next Year Has Fair Amount Of Complexity, Co. Expects Current Factors To Have Financial Outcomes In H2 Next Year

By Michael Horton
November 21, 5:58 PM
-Reuters Citing Conference Call

DELL

Read More
2 minute read
  • FDA
  • General
  • Health Care
  • News

Gamida Cell Provides Regulatory Update On Omidubicel, Says Received Extension Of Omidubicel PDUFA Date From Jan. 30, 2023 To May 1, 2023 As FDA Issued Information Request

By Michael Horton
November 21, 5:54 PM
Gamida Cell Ltd. (NASDAQ:GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematological and solid cancers and other serious diseases, today provided an update on recent

GMDA

Posts pagination

Previous 1 … 102 103 104 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service